Agilent Technologies Operating Cash Flow Per Share 2010-2025 | A
Current and historical operating cash flow per share for Agilent Technologies (A) from 2010 to 2025. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis Agilent Technologies operating cash flow per share for the three months ending January 31, 2025 was $1.50.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.486B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.416B | 27.54 |
| ResMed (RMD) | United States | $35.930B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Baxter (BAX) | United States | $15.857B | 11.84 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.655B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.458B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.18 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.53 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |